Back to search
Pelvic Organ Prolapse (POP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pelvic Organ Prolapse (POP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pelvic Organ Prolapse (POP) trials you may qualify forThe objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine pr…
The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent su…
The AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery. This will be evaluated via a self-r…
Pelvic organ prolapse (POP) is a condition characterized by descent of vaginal walls, uterus and cervix, or the perineum and causes a sensation of vaginal bulge…
This study is a prospective, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effect of paracervical block on early postoper…
This study compares two methods for removing the fallopian tubes and ovaries during vaginal hysterectomy for pelvic organ prolapse. One method uses an energy-b…
The goal of this clinical trial is to compare the Manchester procedure and vaginal hysterectomy in treating patients with symptomatic uterine prolapse. The mai…
Pelvic organ prolapse (POP) is a common health issue. It will impact about half of Canadian women over their lifetime. With POP, organs like the bladder, uterus…
The purpose of this clinical investigation is to collect clinical data about the ProGYNious Mesh based on a prospective clinical investigation. The primary obje…